Number of clinical trials in Finland falls in 2007
This article was originally published in Scrip
Executive Summary
The number of clinical trials conducted in Finland last year fell to 459 from above 500 in 2006, which was an “exceptionally high” number, says Pharma Industry Finland, the national association. One quarter (115) of them involved medicines for CNS disorders, followed by 104 trials for cancer and substances modulating the immune system response. 175 new trials were initiated in 2007 which was nearly an average figure. The number of patients enrolled increased by around 20% to 48,000, with half of them taking part in Phase III trials and almost 40% in Phase IV trials. The majority (80%) were involved in vaccine trials. In the six years to 2007, clinical trials of vaccines prevailed over other products, with seven to 19 studies being conducted in this group every year. Children participated in those of rotavirus, varicella, influenza and human papillomavirus vaccines.